NTRA

Natera, Inc.

Biotechnology · Biotechnology

$91.77 sample

+0.17 (+0.19%) 1D

Market cap

$137.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-05

Alerts

8

Price$91.77 +3.59% 3M daily closessample

92.5886.13

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: 10% owner
Oct 05SECDEF 14A filed
Sep 30INSInsider sell: EVP, Operations
Sep 25INSInsider buy: EVP, Operations
Sep 17INSInsider buy: Chief Executive Officer
Sep 09SEC10-Q filed
Sep 01INSInsider sell: EVP, Operations
Aug 24INSInsider sell: Chief Executive Officer

Sign up to see the real NTRA record →

Company facts

SEC EDGAR registration

Name: Natera, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in NTRA

sample

Insiders: 21 insider transactions over 90 days, net selling, $244.5M
Congress: 4 members traded over 90 days
Institutions · 13F: 35 funds hold $3.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.6B +18.3% y/y

Q4 2024Q3 2026

Inventory$3.2B +8.0% y/y

Q4 2024Q3 2026

Accounts receivable$2.5B +8.1% y/y

Q4 2024Q3 2026

Total debt$6.6B +10.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $46.6B -8.8% 3M
Sample peer B: $84.8B -5.8% 3M
Sample peer C: $126.9B -12.5% 3M
Sample peer D: $129.0B +3.5% 3M
Sample peer E: $130.5B +12.9% 3M